News & Events
Treatment Resistant Depression

Treatment Resistant Depression

If you have depression but your medication is not working or the side effects are intolerable; you may have what is known as treatment resistant depression.
Inside Magstim

Inside Magstim

Take a look inside Magstim. At Magstim, we believe in developing cost-effective, innovative TMS solutions, enabling ground breaking neuroscience research & TMS Therapy. Dr. M. Polson gives us a look inside Magstim and the story of TMS therapy. https://youtu.be/vR-ivzTKcIE Neuromodulation…
Setting up a TMS Clinic

Setting up a TMS Clinic

We spoke to our UK Sales Manager Andrew Dixon, who works with clinics to help them get established, to get his top tips for setting up a TMS clinic:
NHS clinical trial could pave the way for new depression treatment

NHS clinical trial could pave the way for new depression treatment

How we treat depression in the future may be set to change as the NHS begins an unprecedented two year study using transcranial magnetic stimulation (TMS).
What Happens during a TMS treatment?

What Happens during a TMS treatment?

It’s one of the most common questions we get asked. Patients want to know what will happen before, during and after a TMS treatment. Your TMS provider will talk you through what to expect in detail before you start but here is our quick step-by-step guide on what a typical therapy session is like.
How Does Horizon TMS Therapy Compare?

How Does Horizon TMS Therapy Compare?

Looking to buy a TMS therapy system? Find out how the Horizon TMS therapy compares to other systems with this infographic.
Introducing Horizon® Performance

Introducing Horizon® Performance

Magstim, the pioneer of a revolutionary non-invasive treatment for depression, has announced that its latest TMS therapy product, the Horizon Performance, has achieved CE mark regulatory approval and 510(k) clearance from the FDA.
Magstim receive a contract from the Veteran Administration

Magstim receive a contract from the Veteran Administration

Morrisville, NC, October 17, 2017 -- Magstim, a pioneer in the study and development of Transcranial Magnetic Stimulation (TMS), has received a contract from the Veterans Administration to help treat Major Depressive Disorder (MDD) in Veterans who have failed to achieve satisfactory improvement from prior antidepressant medication.
Magstim Group, Inc. appoints Lothar Krinke as New CEO.

Magstim Group, Inc. appoints Lothar Krinke as New CEO.

Magstim Group, Inc., the pioneer in trans-cranial magnetic stimulation and intraoperative nerve monitoring, today announced that it has appointed Lothar Krinke, Ph.D., as Chief Executive Officer effective immediately. Dr. Krinke will serve on the Board of Directors of Magstim. He will be responsible for Magstim and Technomed.

Keep up to date

By signing up you are confirming that you have read, understood and accept our Privacy Policy